Tratamiento hormonal en los pacientes con cáncer de mama de tipo luminal - page 30

Lancet 2016; 388: 2997–3005

Estratificación

- LA vs Metastásica

- QT previa (neo/adj, met):

- SI vs NO

- Enf medible vs no medible

Análisis ITT

Valoración respuesta: Investigador

local

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,20,21,22,23,24,25,26,27,28,29 31,32,33,34,35,36,37,38,39,40,...42